- Home
- PRTA vs NNOX Comparison
PRTA vs NNOX Comparison
Compare PRTA & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- NNOX
- Stock Information
- Founded
- PRTA 2012
- NNOX 2011
- Country
- PRTA Ireland
- NNOX Israel
- Employees
- PRTA N/A
- NNOX N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- PRTA Health Care
- NNOX Health Care
- Exchange
- PRTA Nasdaq
- NNOX Nasdaq
- Market Cap
- PRTA 346.4M
- NNOX 335.1M
- IPO Year
- PRTA N/A
- NNOX 2020
- Fundamental
- Price
- PRTA $6.41
- NNOX $5.06
- Analyst Decision
- PRTA Buy
- NNOX Strong Buy
- Analyst Count
- PRTA 9
- NNOX 2
- Target Price
- PRTA $27.67
- NNOX $9.50
- AVG Volume (30 Days)
- PRTA 1.7M
- NNOX 1.0M
- Earning Date
- PRTA 08-07-2025
- NNOX 08-19-2025
- Dividend Yield
- PRTA N/A
- NNOX N/A
- EPS Growth
- PRTA N/A
- NNOX N/A
- EPS
- PRTA N/A
- NNOX N/A
- Revenue
- PRTA $137,935,000.00
- NNOX $11,545,000.00
- Revenue This Year
- PRTA N/A
- NNOX $23.81
- Revenue Next Year
- PRTA $122.02
- NNOX $149.38
- P/E Ratio
- PRTA N/A
- NNOX N/A
- Revenue Growth
- PRTA 54.55
- NNOX 15.32
- 52 Week Low
- PRTA $4.32
- NNOX $3.75
- 52 Week High
- PRTA $25.42
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- PRTA 57.61
- NNOX 48.70
- Support Level
- PRTA $5.96
- NNOX $5.12
- Resistance Level
- PRTA $6.77
- NNOX $5.35
- Average True Range (ATR)
- PRTA 0.36
- NNOX 0.21
- MACD
- PRTA 0.14
- NNOX 0.00
- Stochastic Oscillator
- PRTA 75.80
- NNOX 66.15
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.